The use of digoxin for atrial fibrillation (AF) treatment has decreased over time in the US, but "without a concomitant increase in the use of other agents for rate control"

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1425, 2004-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Partial A1 Adenosine Receptor Agonists from a Molecular Perspective and Their Potential Use as Chronic Ventricular Rate Control Agents During Atrial Fibrillation (AF)

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 8, 2004-04 ,pp. : 839-854

Bentham Science Publishers

Access to resources Recommend Favorite

Atrial fibrillation (AF) prevalence in US adults could increase approximately 2.5-fold by 2050

By  

Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Use of -Blockers in Atrial Fibrillation

By Kühlkamp V.   Bosch R.   Mewis C.   Seipel L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. : 37-42

Adis International

Access to resources Recommend Favorite

Rate Control in Atrial Fibrillation: Choice of Treatment and Assessment of Efficacy

By Boriani G.   Biffi M.   Diemberger I.   Martignani C.   Branzi A.  

Drugs, Vol. 63, Iss. 14, 2003-01 ,pp. : 1489-1509

Adis International

Access to resources Recommend Favorite

Postoperative NSAID use is associated with a decrease in the odds of developing atrial fibrillation (AF) after cardiothoracic surgery

By  

Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite